Life Science Medical Billing Pharmaceuticals 
Health Populi
FEBRUARY 24, 2020
And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and life science organizations. Even trust with pharmaceutical companies increased that year.
Health Populi
OCTOBER 15, 2019
These study respondents had also visited a doctor or hospital and paid a medical bill in the past year. One-third of these patients had a health care bill go to collections in the past year, according to Cedar’s 2019 U.S. 50% want clearer, easier-to-understand medical bills.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 26, 2025
Tom Lawry may be best-known as a leading voice on AI in health care; after all, hes written two very well-selling books on the topic, speaks all over the world on the subject, and in his most recent company-based gig helped lead Microsofts efforts in AI in health care and life sciences.
Health Populi
OCTOBER 12, 2022
Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. You can download the paper at this link. The post The Patient as Prescription Drug Payer – The GoodRx Playbook appeared first on HealthPopuli.com.
Health Populi
MARCH 11, 2021
Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.
Health Populi
OCTOBER 28, 2019
84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers. Exacerbating U.S.
Health Populi
MARCH 6, 2024
It takes a village to address gender health equity: the report concludes that the issue does not stand-alone — and requires the community of education, government, life science innovators, philanthropists, activists and business to recognize and address this challenge.
Expert insights. Personalized for you.
240 
Let's personalize your content